Allergan CEO says Botox maker's new depression drug could be an 'absolute game-changer'
April 30, 2018 at 18:22 PM EDT
Jim Cramer sits down with Allergan Chairman and CEO Brent Saunders after earnings to hear about the pharmaceutical giant's latest ventures.